AAV9 (adeno-associated virus serotype 9)

AAV9, or adeno-associated virus serotype 9, is a small virus that is often used in gene therapy. It can deliver genetic material into cells without causing disease, making it a valuable tool for researchers and healthcare providers. AAV9 has a unique ability to target and enter specific types of cells, especially those in the brain and heart, which can be beneficial for treating genetic disorders. Its safety profile and efficiency in gene delivery make it a promising option for developing new treatments for various diseases, including conditions like spinal muscular atrophy.